Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q60207426)
Watch
English
Anti-TNF-α therapy for uveitis: Behçet and beyond
scientific article published on 01 August 2005
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
title
Anti-TNF-alpha therapy for uveitis: Behçet and beyond
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
main subject
TNF
0 references
Behçet's disease
0 references
TNF inhibitor
0 references
uveitis
1 reference
based on heuristic
inferred from title
author
Philip I. Murray
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
author name string
Sivaraj RR
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
publication date
1 August 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
published in
Eye
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
volume
19
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
issue
8
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
page(s)
831-833
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
exact match
https://scigraph.springernature.com/pub.10.1038/sj.eye.6701792
0 references
cites work
Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etanercept treatment in the endotoxin-induced uveitis of rats.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etanercept therapy in children with treatment-resistant uveitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by Methotrexate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of infliximab on threatening panuveitis in Behçet's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab in the treatment of refractory posterior uveitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab for chronic cystoid macular edema associated with uveitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.EYE.6701792
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/SJ.EYE.6701792
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
PubMed ID
16086039
1 reference
stated in
Europe PubMed Central
PubMed ID
16086039
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086039%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
